Comparative Transcriptome Analysis Reveals That Exendin-4 Improves Steatosis in HepG2 Cells by Modulating Signaling Pathways Related to Lipid Metabolism
<p dir="ltr">No therapy exists for non-alcoholic fatty liver disease (NAFLD). However, glucagon-like peptide receptor agonists (GLP-1RAs) showed a beneficial effect on NAFLD, although the underpinning mechanisms remain unclear due to their pleiotropic effects. We examined the implica...
Saved in:
| Main Author: | Khaoula Errafii (10914446) (author) |
|---|---|
| Other Authors: | Olfa Khalifa (10914452) (author), Neyla S. Al-Akl (10914449) (author), Abdelilah Arredouani (10914455) (author) |
| Published: |
2022
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells
by: Olfa Khalifa (10914452)
Published: (2023) -
Long non-coding RNA MALAT1 promotes steatosis in HepG2 cells by modulating target gene expression in presence of Exendin-4
by: Olfa Khalifa (10914452)
Published: (2023) -
Investigation of the Effect of Exendin-4 on Oleic Acid-Induced Steatosis in HepG2 Cells Using Fourier Transform Infrared Spectroscopy
by: Olfa Khalifa (10914452)
Published: (2022) -
Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4
by: Khaoula Errafii (10914446)
Published: (2021) -
GLP-1 receptor agonists, are we witnessing the emergence of a paradigm shift for neuro-cardio-metabolic disorders?
by: Abdelilah Arredouani (10914455)
Published: (2025)